Amyris Fights Claims In Cannabis IP Row By Defining 'Under'
Biotechnology company Amyris Inc. said Tuesday the word "under" in a contract between it and cannabinoid manufacturer Lavvan supports its effort to quash two claims Lavvan has filed against the debtor,...To view the full article, register now.
Already a subscriber? Click here to view full article